CN101555213A - Preparation method of N-(phenelyl)-2-hydroxybenzamide - Google Patents

Preparation method of N-(phenelyl)-2-hydroxybenzamide Download PDF

Info

Publication number
CN101555213A
CN101555213A CNA2009100591710A CN200910059171A CN101555213A CN 101555213 A CN101555213 A CN 101555213A CN A2009100591710 A CNA2009100591710 A CN A2009100591710A CN 200910059171 A CN200910059171 A CN 200910059171A CN 101555213 A CN101555213 A CN 101555213A
Authority
CN
China
Prior art keywords
preparation
phenelyl
hydroxybenzamide
reaction
bigcatkin willow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2009100591710A
Other languages
Chinese (zh)
Inventor
黎鹏
王勇
杨军
潘野
廖文武
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHENGDU QIAOFENG TECHNOLOGICAL DEVELOPMENT Co Ltd
Original Assignee
CHENGDU QIAOFENG TECHNOLOGICAL DEVELOPMENT Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHENGDU QIAOFENG TECHNOLOGICAL DEVELOPMENT Co Ltd filed Critical CHENGDU QIAOFENG TECHNOLOGICAL DEVELOPMENT Co Ltd
Priority to CNA2009100591710A priority Critical patent/CN101555213A/en
Publication of CN101555213A publication Critical patent/CN101555213A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the technical field of medicine and discloses a preparation method of N-(phenelyl)-2-hydroxybenzamide. The method is characterized in that salicylic acid is firstly prepared into salicyloyl chloride and then reacted with 4-ethoxyaniline to obtain N-(phenelyl)-2-hydroxybenzamide. The method has the advantages of few reaction process, mild reaction condition, high yield, fine product purity and low cost which are applicable to industrial production.

Description

The preparation method of N-(phenelyl)-2-hydroxybenzamide
Technical field:
The invention belongs to medical technical field, be specifically related to the preparation method of N-(phenelyl)-2-hydroxybenzamide.
Background technology:
N-(phenelyl)-2-hydroxybenzamide (ethoxy benzene willow amine) is a kind of nonsteroidal anti-inflammatory Claritin, be the kind new medicine that China develops voluntarily, clinical study finds that N-(phenelyl)-2-hydroxybenzamide has obviously definite curative effect to neurodermatitis, eczema, acne.
Chinese patent CN1050588A discloses the synthetic method of a kind of N-(phenelyl)-2-hydroxybenzamide. promptly: earlier Whitfield's ointment is made phenyl ester or methyl esters, carry out the ester amine exchange reaction with the 4-phenetidine then and obtain target compound, ester amine exchange reaction temperature is many more than 130 ℃ in this method, find in the actually operating because temperature of reaction is very high, make in the final product impure more, and the product color is deep, has influenced the quality of finished product.In the disclosed N-of Chinese patent CN1166484A and CN101085746A (phenelyl)-2-hydroxybenzamide synthetic method, used a large amount of benzene class aromatic hydrocarbons as reaction solvent, though reaction yield is than higher, but because benzene class aromatic hydrocarbons great majority all have more intense toxicity, therefore scale operation is restricted, and is unfavorable for environmental protection and HUMAN HEALTH.
Summary of the invention:
The objective of the invention is to overcome present N-(phenelyl)-2-hydroxybenzamide preparation method's deficiency, provide a kind of raw material economics to be easy to get, reaction scheme is short, reaction conditions is gentle, yield is high, the preparation method of good product purity.
The objective of the invention is to be achieved through the following technical solutions:
Preparation method of the present invention is undertaken by following reaction scheme:
Whitfield's ointment is mixed with sulfur oxychloride, and back flow reaction obtains the bigcatkin willow acyl chlorides under the situation of not using any solvent.
The bigcatkin willow acyl chlorides is mixed with the 4-phenetidine, with organic bases or mineral alkali as acid scavenger, in aprotic polar solvent, react and obtain N-(phenelyl)-2-hydroxybenzamide, the acid scavenger that adopts is specially: Anhydrous potassium carbonate, triethylamine, pyridine, reaction solvent is specially: DMF, methylene dichloride or acetone.
The starting raw material that the present invention selects is simple and easy to, and cheap, reaction scheme is short, and the reaction conditions gentleness does not produce the strong acid and strong base waste material, and post-reaction treatment is easy, and preparation yield height is suitable for industrialized production.
The invention will be further described by the following examples, it should be noted that reaction conditions and raw material purpose that following examples are related are the present invention is done better explanation, rather than limitation of the present invention.
Embodiment
Embodiment 1
The preparation of bigcatkin willow acyl chlorides
13.7g (0.1mol) Whitfield's ointment is mixed with 23.8g (0.2mol) sulfur oxychloride, and back flow reaction is 30 minutes under stirring, and removes excessive sulfur oxychloride in underpressure distillation below 50 ℃, obtains colorless oil 15.5g.
1H-NMR(CDCl 3):4.92(s,1H);6.91(d,1H);7.05(m,1H);7.46(m,1H);7.94(d,1H)。
Embodiment 2
The preparation of N-(phenelyl)-2-hydroxybenzamide
31.3g (0.2mol) bigcatkin willow acyl chlorides is dissolved in the 200ml dry DMF, stir and add 24.7g (0.18mol) 4-phenetidine down, mixture is cooled to 0 ℃ subsequently, add Anhydrous potassium carbonate 33.1g (0.24mol), be warming up to stirring at room reaction 2 hours after 4 hours in 0 ℃ of stirring reaction.In reaction solution, add the 500ml frozen water, stirred 1 hour, use the ethyl acetate extraction reaction solution, tell ethyl acetate, water, saturated common salt water washing successively, anhydrous magnesium sulfate drying, concentrating under reduced pressure obtains light yellow solid 42.5g.Use recrystallization from ethyl acetate/petroleum ether, obtain white solid 38 4g. yields 83%.Fusing point: 140.5~142 ℃. 1H-NMR(CDCl 3):1.33(t.3H);3.95(q,2H);5.05(s,1H);6.72(d,2H);6.93(d,1H);6.98(m,1H);7.31(m,1H);7.59(d,2H);7.78(d,1H);8.14(s,br,1H)。
Embodiment 3
The preparation of N-(phenelyl)-2-hydroxybenzamide
31.3g (0.2mol) bigcatkin willow acyl chlorides is dissolved in the 150ml acetone, stir and add 24.7g (0.18mol) 4-phenetidine down, mixture is cooled to 0 ℃ subsequently, slowly dripped pyridine 23.7g (0.3mol) in 2 hour time, after dropwising, keep this temperature to continue to stir 2 hours, be warming up to stirring at room reaction 2 hours subsequently, solids removed by filtration, with the reaction solution evaporate to dryness, add 200ml water, use ethyl acetate extraction, tell ethyl acetate, water, saturated common salt water washing successively, anhydrous magnesium sulfate drying, concentrating under reduced pressure obtains light yellow solid 41.6g.Use recrystallization from ethyl acetate/petroleum ether, obtain white solid 35.9g, yield 78%.Fusing point: 140.5~141.5 ℃. 1H-NMR(CDCl 3):1.33(t,3H);3.95(q,2H);5.05(s,1H);6.72(d,2H);6.93(d,1H);6.98(m,1H);7.31(m,1H);7.59(d,2H);7.78(d,1H);8.14(s,br,1H)。
Embodiment 4
The preparation of N-(phenelyl)-2-hydroxybenzamide
31.3g (0.2mol) bigcatkin willow acyl chlorides is dissolved in the 150ml methylene dichloride, stir and add 24.7g (0.18mol) 4-phenetidine down, mixture is cooled to 0 ℃ subsequently, slowly dripped triethylamine 30g (0.3mol) in 2 hour time, after dropwising, keep this temperature to continue to stir 2 hours, be warming up to stirring at room reaction 1 hour subsequently, solids removed by filtration, with the reaction solution evaporate to dryness, add 200ml water, use ethyl acetate extraction, tell ethyl acetate, water successively, the saturated common salt water washing, anhydrous magnesium sulfate drying, concentrating under reduced pressure obtains light yellow solid 43.1g.Use recrystallization from ethyl acetate/petroleum ether, obtain white solid 40.2g, yield 87%.Fusing point: 141~142 ℃. 1H-NMR(CDCl 3):1.33(t,3H);3.95(q,2H);5.05(s,1H);6.72(d,2H);6.93(d,1H);6.98(m,1H);7.31(m,1H);7.59(d,2H);7.78(d,1H);8.14(s,br,1H)。

Claims (6)

1. the preparation method of a N-(phenelyl)-2-hydroxybenzamide is characterized in that earlier Whitfield's ointment being made the bigcatkin willow acyl chlorides, obtains N-(phenelyl)-2-hydroxybenzamide with the reaction of 4-phenetidine again.
2. preparation method according to claim 1 when preparing the bigcatkin willow acyl chlorides by Whitfield's ointment, except acid of reactant bigcatkin willow and sulfur oxychloride, does not use any solvent.
3. preparation method according to claim 1, during preparation N-(phenelyl)-2-hydroxybenzamide, the solvent that uses is methylene dichloride, acetone or DMF.
4. preparation method according to claim 1, during preparation N-(phenelyl)-2-hydroxybenzamide, the acid scavenger that uses is triethylamine, Anhydrous potassium carbonate or pyridine.
5. preparation method according to claim 1, during preparation N-(phenelyl)-2-hydroxybenzamide, range of reaction temperature at 0 ℃ between the room temperature.
6. preparation method according to claim 1, during preparation N-(phenelyl)-2-hydroxybenzamide, the reaction times is 1 to 10 hour.
CNA2009100591710A 2009-05-04 2009-05-04 Preparation method of N-(phenelyl)-2-hydroxybenzamide Pending CN101555213A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2009100591710A CN101555213A (en) 2009-05-04 2009-05-04 Preparation method of N-(phenelyl)-2-hydroxybenzamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2009100591710A CN101555213A (en) 2009-05-04 2009-05-04 Preparation method of N-(phenelyl)-2-hydroxybenzamide

Publications (1)

Publication Number Publication Date
CN101555213A true CN101555213A (en) 2009-10-14

Family

ID=41173515

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2009100591710A Pending CN101555213A (en) 2009-05-04 2009-05-04 Preparation method of N-(phenelyl)-2-hydroxybenzamide

Country Status (1)

Country Link
CN (1) CN101555213A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108727442A (en) * 2018-04-21 2018-11-02 浙江大学 A kind of preparation method and applications of Osalmid glucuronidation product

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108727442A (en) * 2018-04-21 2018-11-02 浙江大学 A kind of preparation method and applications of Osalmid glucuronidation product

Similar Documents

Publication Publication Date Title
ES2599752T3 (en) Production method of a 4,4-difluoro-3,4-dihydroisoquinoline derivative
CN104045637B (en) A kind of preparation method of Eliquis
CN105330609B (en) A kind of method for preparing LCZ696
CN104974060A (en) Method for preparing sodium, 8-(2-hydroxybenzamido)octanoate
CN102329277B (en) Method for preparing Parecoxib
CN105859664A (en) Firocoxib preparation method
CN102516122A (en) Environment friendly method for preparing DMF (Dimethyl Formamide) solution of 2-hydroxy-benzonitril, DMF solution of 2-hydroxy-benzonitril and application thereof
CN100361972C (en) Synthesis of tenuazonic acid and iso-tenuazonic acid
CN106467513A (en) A kind of synthetic method preparing Niraparib
CN105622538B (en) One kettle way prepares Cetilistat in high yield
CN104974057B (en) The preparation method and important intermediate of a kind of bromfenac sodium
CN108586399A (en) A kind of synthetic method of Fei Luokao former times
CN101585778B (en) Lyrica preparation method
CN101555213A (en) Preparation method of N-(phenelyl)-2-hydroxybenzamide
CN104230743B (en) Method for preparing 4-benzyl-1-phenethyl piperazine-2,6-diketone
CN106831457B (en) A kind of preparation method of 3- amino -2- hydroxy acetophenone
CN107235853B (en) A kind of synthetic method being used to prepare Canton love-pea vine A prime and its isomers
CN103113408B (en) A kind of novel method preparing phosphonomycin fosfomycin phenylethylamine calt
CN101012192A (en) Method of preparing zofenopril calcium
CN106674281B (en) A kind of Rosuvastatin midbody compound, preparation method and its usage
CN101768095A (en) Preparation method of racecadotril
CN103922948A (en) Preparation method of 2-amino-3-nitrobenzoic acid
CN102796056B (en) Peramivir intermediate and preparation method for analogue
CN102344392B (en) Method for refining histone deacetylase (HDAC) inhibitor vorinostat
CN109280027A (en) A kind of synthetic method of 5,6- dimethoxy -2- pyridine carboxylic acid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20091014